LEV Psychiatric Side Effects – Brivaracetam Switch — SCE Neurology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Levetiracetam-induced psychiatric adverse effects (irritability, agitation, aggression) — occurring in approximately 5–10% of patients; consider dose reduction or switching to brivaracetam (which has the same SV2A target but lower psychiatric side effect profile)
Levetiracetam commonly causes psychiatric adverse effects: irritability (~10%), agitation, aggressive behaviour, anxiety, depression, and rarely psychosis. These are dose-related and more common in patients with a prior psychiatric history (though they can occur de novo). Management: (1) dose reduction may improve symptoms while maintaining seizure control, (2) switching to brivaracetam (same SV2A target, higher affinity, fewer psychiatric side effects), (3) if continuing LEV, adding a low-dose SSRI or pyridoxine (B6 — anecdotal evidence) may help. A: Drug-induced, not personality change. C: This is a direct drug effect, not idiopathic depression. D: The temporal relationship to LEV initiation confirms the cause. E: No prior psychiatric history.
Reference: BNF – Levetiracetam; NICE NG217